KPMA mulls measures to assist seminars in bona fide

Published: 2007-11-01 06:59:00

Updated: 2007-11-01 06:59:00

The Korea Pharmaceutical Manufacturers Association is now gauging the gravity of the impact that the Fair Trade Commission's wide graft probe would have on the local pharmaceutical industry, while it is studying to provide doctors with financial support for seminars or congress at home and abroad...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK